Acceleron Pharma reported $-63662000 in EBIT for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Acceleron Pharma XLRN:US $ -63662000 59K
Alexion Pharmaceuticals ALXN:US $ 816.7M 185.9M
Amgen AMGN:US $ 2333M 204M
Arena Pharmaceuticals ARNA:US $ -144391000 12.4M
Bayer BAYN:GR 1.64B 1.42B
Biomarin Pharmaceutical BMRN:US $ 13.86M 13.56M
Bluebird Bio BLUE:US $ -240791000 9.95M
Dicerna Pharmaceuticals DRNA:US $ -40244000 11.14M
Eli Lilly And LLY:US $ 1428.4M 237.8M
Exelixis EXEL:US $ 123.01M 127.62M
Gilead Sciences GILD:US $ 2262M 639M
GlaxoSmithKline GSK:LN 1.96B 281M
Johnson & Johnson JNJ:US $ 6901M 94M
Karyopharm Therapeutics KPTI:US $ -49048000 3.32M
Mirati Therapeutics MRTX:US $ -164186000 31.76M
Neurocrine Biosciences NBIX:US $ 67.8M 36.3M
Novartis NOVN:VX 3.4B 415M
Pfizer PFE:US $ 6662M 905M
Ptc Therapeutics PTCT:US $ -98493000 345K
Puma Biotechnology PBYI:US $ -16633000 36.78M
Regeneron Pharmaceuticals REGN:US $ 3347.2M 2234.5M
Rigel Pharmaceuticals RIGL:US $ -13048000 54.8M
Sangamo Biosciences SGMO:US $ -48700000 2.4M
Tg Therapeutics TGTX:US $ -77492000 11.71M
Ultragenyx Pharmaceutical RARE:US $ -82776000 23.79M
United Therapeutics UTHR:US $ 222.2M 263.9M
Vertex Pharmaceuticals VRTX:US $ -36.36M 920.29M